The down-scheduling of MDMA and psilocybin(e): Too fast and too soon.
No abstract is available for this record.
Bibliographic context
- Journal
- Unknown
- Date
- 2023-05-09
- Source
- Europe PMC
- PubMed
- 37161273
Topics and keywords
Citation graph
0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.
Related papers
Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression.Journal of Affective Disorders · 2018-03-31Medical Uses and Adverse Effects of PsilocybinThe Primary Care Companion For CNS Disorders · 2024-05-26Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patientsJournal of Affective Disorders · 2022-12-09An episode of mania following self-reported ingestion of psilocybin mushrooms in a woman previously not diagnosed with bipolar disorder: A case report.Bipolar Disorders · 2021-05-17Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions.International Journal of Eating Disorders · 2026-07-01Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depressionJournal of Affective Disorders · 2026-06-03CAPSI - Cancer Related Major Depression Treated With a Single Dose of Psilocybin: A Multicenter Randomized Placebo Controlled Double Blind Clinical TrialClinicalTrials.gov · 2026-04-12The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-03-22